Research Impact: Geospatial Factors Applied to Road Accidents
Road accidents are a major source of trauma worldwide. Over 1.3 million people are killed in road accidents annually, and collisions are a leading cause of death and injury across all age groups. Aside from the human cost of road accidents, there is a significant financial toll. The US Centre for Disease Control and Prevention […]
AARNet
AARNet is Australia’s national research and education network, a not-for-profit organisation equally owned by 38 Australian universities and CSIRO. AARNet provides essential high-speed internet and advanced network services tailored to meet the specialised needs of researchers in Australia.
TRI boosts medical research efficiency with FileSender
The Translational Research Institute’s integration of FileSender enables fast and secure data sharing, streamlining collaboration for vital medical research. The Translational Research Institute (TRI) is at the forefront of medical research, supporting diverse research projects that produce crucial data to further our understanding of complex diseases. The institute plays a key role in studies spanning cancer biology, […]
Making visible the impact of Australia’s national microscopy infrastructure
Through trust and identity, the impact of Australia’s distributed microscopy infrastructure will be revealed. Microscopy Australia is a consortium of university-based microscopy facilities that provides more than 3,500 Australian researchers a year, with access to state-of the-art microscopes. Through access to their facilities, crucial research is enabled in areas such as future energy innovations, improved […]
Unlocking the power of Australia’s Tier 1 supercomputer
Through a national framework for trusted identity, accessing one of Australia’s Tier 1 supercomputers will become easier. The Pawsey Supercomputing Research Centre (Pawsey) is one of two Tier-1 high-performance computing facilities in Australia. Its primary function is to accelerate scientific research for the benefit of the nation. Pawsey’s service and expertise in supercomputing, data, cloud […]
State support injects big cash for upgrades and new national research infrastructure
National Collaborative Research Infrastructure Strategy (NCRIS)-supported programs have received nearly $30 million in co-investment from the New South Wales and Queensland Governments through the NCRIS Support Program and Research Infrastructure Co-Investment Fund (RICF), respectively. Co-funding arrangements such as the NCRIS Support Program and RICF are another way that NCRIS ensures that spending on research infrastructure […]
Future-proofing computational proteomics
EMBL Australia and Bioplatforms Australia joined forces to host a pivotal proteomics workshop titled ‘Future-proofing Computational Proteomics’ on 24 April, featuring leading guest speakers, Dr Rolf Apweiler, Prof Marc Wilkins and Dr Richard Lipscombe. The Australian proteomics community discussed advancements in proteomics research and the pivotal role of computational approaches in shaping the future of […]
Australian health research infrastructure underpins world-first brain cancer collaboration
The NCRIS Health Group will support Australian brain cancer research through Brain Cancer Australia’s project to develop an integrated network of research platforms to improve patient outcomes, test new treatments and work toward a cure, with the announcement of a Medical Research Future Fund (MRFF) grant worth just under $6M. The project brings together clinicians, […]
Centre for Accelerator Science (ANSTO – Nuclear Science Facilities)
ANSTO’s Centre for Accelerator Science (CAS) is one of two landmark research infrastructure facilities supported by NCRIS through the funded Nuclear Science Facilities (NSF) program. CAS provides ultra-sensitive sample characterisation, dating, materials modification and irradiation to research and industry users from Australia and the world to solve complex questions and problems.
Therapeutic Innovation Australia (TIA)
Therapeutic Innovation Australia (TIA) is the lead agent for the NCRIS “Therapeutic Innovation Australia” project. TIA a national consortium of translational research infrastructure that provides researchers and SMEs the expertise and capabilities required to move a potential therapeutic product along the development pathway.
National Deuteration Facility (NDF)
ANSTO’s National Deuteration Facility (NDF) is an NCRIS funded program which created and supports Australia’s only molecular deuteration facility. NDF provides access to landmark infrastructure and expertise for chemical and biological deuteration capabilities, facilitating world-leading research for Australian users to address complex challenges in industrial, medical and environmental applications.
Australian Research Data Commons (ARDC)
The Australian Research Data Commons (ARDC) provides Australian researchers with competitive advantage through data. It accelerates research and innovation by driving excellence in the creation, analysis and retention of high-quality data assets. The ARDC is enabled by the National Collaborative Research Infrastructure Strategy (NCRIS). NCRIS is a national network of world-class research infrastructure projects that support high-quality research that will drive greater innovation in the Australian research sector and the economy more broadly.
Australian Centre for Neutron Scattering (ANSTO – Nuclear Science Facilities)
ANSTO’s Australian Centre for Neutron Scattering (ACNS) is one of two landmark research infrastructure facilities supported by NCRIS through the funded Nuclear Science Facilities (NSF) program. ACNS uses neutrons from Australia’s multi-purpose research reactor, OPAL, to solve complex research questions and industrial problems for Australian and International users. Neutron scattering techniques allow the structure and dynamics of materials to be determined, permitting scientists and industry to understand why materials have the properties they do, and helping tailor new materials, devices and systems.
National Imaging Facility (NIF)
National Imaging Facility (NIF) is Australia’s advanced imaging network. We provide open access to world-class imaging equipment, expertise, tools, data and analysis. We address Australia’s strategic science and research priorities, and this benefits Australian industry and helps keep Australians healthy.
Australian Access Federation (AAF)
The Australian Access Federation (AAF) is Australia’s leading provider of identity and access management services to the education and research sector. We make it easy for people to securely access education and research services nationally and internationally, by providing single sign-on. It allows individuals from different organisations to collaborate and access online resources within a trusted environment.
Pawsey Supercomputing Research Centre (Pawsey)
Pawsey Supercomputing Research Centre, Australia’s leading Tier-1 high-performance computing facility, is advancing research and innovation by providing cutting-edge supercomputing, data and visualisation infrastructure and expertise. From accelerating breakthroughs in medicine and climate science to unlocking the mysteries of the universe, Pawsey is at the forefront of driving discovery and advancing knowledge.
Population Health Research Network (PHRN)
The Population Health Research Network (PHRN) has been at the forefront of integrating health and human services data across Australia. With a robust network of data linkage units, PHRN empowers researchers to unlock insights into disease, shaping innovative treatments and enhancing health services nationwide. Underpinned by a commitment to privacy and ethical standards, PHRN exemplifies collaborative research, bolstered by substantial support from government and academic sectors.
EMBL Australia
EMBL Australia is a life science network that supports ambitious research projects and provides access to infrastructure and training to early-career Australian scientists. Through Australia’s associate membership of the European Molecular Biology Laboratory (EMBL), Australian researchers can access EMBL’s broad range of world-class infrastructures and international expertise.
Bioplatforms Australia (BPA)
We provide access to ‘omics technologies in support of all life science researchers working across human health, agriculture, biodiversity and industry. Bioplatforms is enabled by the Australian Government’s National Collaborative Research Infrastructure Strategy (NCRIS).
Phenomics Australia (PA)
Phenomics Australia provides a national capability to explore the human genome and the genetic basis of health and disease. Our openly accessible service delivery centres span twenty locations across Australia. Through these, we offer specialised infrastructure, research services and technical expertise dedicated to advancing our fundamental understanding of health and disease and enabling next-generation innovations in healthcare and therapeutic development to benefit all Australians.
Microscopy Australia (MicroAu)
Microscopy Australia provides researchers and industry with open access to the nation’s largest range of high-end microscopes, microanalysis tools, and specialists. It consists of university-based microscopy centres around the country. Our instruments have dedicated experts to deliver high quality training and support to ensure you get the best research outcomes.
Australian National Fabrication Facility (ANFF)
ANFF owns and provides access to micro and nanofabrication capabilities for Australia’s researchers and industry. We can assist in both the development of new products and improvements to current production methods. Each Node provides expertise in a specific area, including advanced materials, nanoelectronics & photonics and nano-bio applications. The ANFF commitment to providing a world-class, open-access user facility is underpinned by the sharing of best practice in service provision across the network.
Heavy Ion Accelerators (HIA)
Our $150M world-class accelerator facilities for high-energy ion beam research represents decades of strategic investment by the Australian National University, the University of Melbourne, our industry partners and the Australian Government. With R&D capabilities unparalleled in Australia and matched by few globally, we support research activities in sectors of national priority, including quantum computing, space and astronomy, advanced materials, environment and climate, cancer therapies, minerals exploration, and fundamental nuclear science.
Protein discovery for better bowel cancer treatments
Bowel cancer claims more than 100 lives in Australia every week. Thankfully, researchers at the Australian National University (ANU) have discovered that an immune protein can slow the division of bowel cancer cells. This is a promising target for both early detection tests and bowel cancer treatments. DR ABHIMANU PANDEY SAYS AN IMMUNE SYSTEM PROTEIN […]
Strengthening our European connections to EMBL and beyond
On a recent visit to EMBL Heidelberg, Ian Smith, Chair of the EMBL Australia Council, spoke about the synergies between EMBL and EMBL Australia, opportunities for collaboration and ideas for exciting future programs. Ian Smith, Chair of the EMBL Australia Council, chatted to EMBL about the synergies between the organisations, opportunities for collaboration, and ideas […]
Clinical Trial Data Unlocked for Research with New National Platform
Health Data Australia is unlocking clinical trial data for research at a national scale. For the first time in Australia, researchers can find clinical trial data from multiple research institutions and request access to it via a new platform, Health Data Australia. Launching tomorrow at SAHMRI in Adelaide, Health Data Australia allows clinical trialists and data […]
Vaccine patch delivers protection from dengue in mice
Dengue is the most significant mosquito-borne viral disease in the world. With an estimated 390 million cases annually, it results in approximately US$6.9 billion in economic losses. Now Dr David Muller and the vaccine team at the University of Queensland (UQ) have developed a promising dengue vaccine candidate that provides strong immunity in mice when […]
Renewable, versatile spinifex and the future of nanofibres
From nanotechnology to Indigenous empowerment Spinifex, a hardy Australian grass, spread widely across inland Australia, presents a new high-tech opportunity for the future of construction, medical technology, and day-to-day life. In partnership with the Indjalandji-Dhidhanu People of North-West Queensland, through Bulugudu Ltd, researchers at the University of Queensland have been developing a high-tech product from […]
Biobanks: the Australian Phenome Bank
The Australian Phenome Bank: a national biobank and database aiding the discovery of genetic disease causes and advancing Personalised Medicine. Phenomics Australia’s Biobanking service provides a database and cryobank of mouse sperm and embryos essential for discovering and distributing disease models in Australia. The challenge: Ensuring the ongoing availability of mouse strains preserving the investment made in […]
CRISPR/Cas as diagnostics tools
Phenomics Australia NCRIS expertise is used in providing knowledge to look into the commercial and translational potential of CRISPR technology. Phenomics Australia’s long-term support of the In vivo Genome Engineering and Disease Modelling nodes over the years has allowed researchers at the Melbourne Advanced Genome Editing Center (MAGEC) to have a solid understanding of CRISPR/Cas […]
When food kills
Infrastructure and expertise supported by Phenomics Australia and Therapeutic Innovation Australia (TIA)are used in fighting food poisoning toxins. Prof Si Ming Man (right) and Dr Anukriti Mathur (left). Image Lannon Harley/ANU The challenge: Food poisoning is estimated to affect more than 4 million Australians every year – costing the economy $1.25 billion, and in some […]
Our One Health approach to Japanese encephalitis
Japanese encephalitis (JE) virus is a potentially fatal disease that infects about 100,000 people worldwide every year. Caused by an arbovirus (an arthropod-borne virus), it is transmitted by mosquitoes. Most JE virus infections in people cause no symptoms, but in rare cases it can develop into a serious infection of the brain called encephalitis. JE […]
How data linkage can improve the health of older people
Older people, despite bearing the burden of chronic disease and being more likely to take prescription drugs older people are under-represented in clinical trials. Studying older people When pharmaceutical companies do clinical trials, people over the age of 70 are often excluded. It’s partly ageism, says Professor Leon Flicker, a geriatric medicine specialist at The University of Western Australia. […]
WearOptimo create real-time, Microwearable health sensors
WearOptimo have used Microscopy Australia’s facilities to develop a world-first, wearable, real-time health sensor, which is now in clinical trials. WearOptimo aims to provide affordable, wearable technology to revolutionise monitoring of biomarkers, which act as an early warning sign of disease. Initially, their sticker like device will provide real time monitoring of hydration and of heart […]
How Australia’s national research infrastructure is responding to COVID-19
Australia’s National Research Infrastructure (NRI) swiftly redeployed to support national and international COVID-19 research. Some examples are listed below. Australian Centre for Disease Preparedness (ACDP), Bioplatforms Australia (BPA), Microscopy Australia and Therapautic Innovation Australia (TIA) were involved in the University of Queensland vaccine program. Australian Plant Phenomics Facility (APPF) is supporting research into plant-based vaccines. Astronomy Australia […]
The risk of ‘Mr Fluffy’ insulation
When Australian National University epidemiologist Associate Professor Rosemary Korda first started holding public forums for Canberra residents affected by ‘Mr Fluffy’ insulation, people were very distressed. “There was quite a bit of anger in the room, and pretty upset people,” she remembers. “There were definitely people who were very concerned about future health effects of the […]
From ancient grass to modern materials
A unique partnership between Dugalunji Aboriginal Corporation and a University of Queensland research team has lead to the development of valuable and sustainable nanofibres leading to the creation of regional, Indigenous jobs. Challenge Nanofibres can strengthen many materials for a wide range of applications from thinner more flexible electronics and plastics, to next generation building […]
Better cholesterol imaging
An international team of researchers has developed a new way to localise cholesterol is in cells and tissues. This provides insights into how cholesterol moves in and out of cells and could eventually lead to new therapies for cardiovascular disease. Deuterated cholesterol enabled by the National Deuteration Facility and NanoSIMS (nano-Secondary Ion Mass Spectroscopy) at […]
Linked Data and the Reduction in Cervical Cancer in Australia
Data linkage has had a significant role in the reduction in cervical cancer in Australia. Preventing cervical cancer The Human Papilloma Virus (HPV) vaccine is a powerful tool for the prevention of cervical cancer. It was developed by industry, based on critical research done at the University of Queensland. Australia was the first country in the world to introduce […]
